BeyondSpring Inc. (NASDAQ:BYSI – Get Free Report) crossed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $1.67 and traded as low as $1.34. BeyondSpring shares last traded at $1.34, with a volume of 45,205 shares changing hands.
BeyondSpring Trading Down 10.7 %
The firm has a fifty day moving average of $1.67 and a two-hundred day moving average of $1.84.
BeyondSpring Company Profile
BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia.
Featured Articles
- Five stocks we like better than BeyondSpring
- Where to Find Earnings Call Transcripts
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- Investing in Construction Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- How to Effectively Use the MarketBeat Ratings Screener
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for BeyondSpring Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BeyondSpring and related companies with MarketBeat.com's FREE daily email newsletter.
